DONATE

Amayra Hernández-Vega receives a grant from the Pasqual Maragall Foundation to advance research on the early stages of Alzheimer’s

IBEC researcher Amayra Hernández-Vega has been awarded a grant from the Pasqual Maragall Researchers Programme to lead a project focused on studying the earliest stages of Alzheimer’s disease. The study will combine in vitro and human models of familial Alzheimer’s disease to identify age-related factors and potential inhibitors that could slow the early progression of the disease. The project was presented at an informative session on sleep and brain health, which was attended by around 500 people.

Josep Samitier concludes thirteen years at the helm of IBEC

Josep Samitier will step down as Director of the Institute for Bioengineering of Catalonia (IBEC) on 31 December 2025. Under his leadership since 2013, IBEC has become a leading institution in Spain for research excellence in bioengineering. Manuel Salmeron, an ICREA Research Professor at IBEC, will take over as interim director at the request of the Institute’s board of trustees.

The IBEC and West China Hospital hold their third joint conference on precision medicine in Barcelona

Barcelona hosted the third IBEC-WCH Precision Medicine Conference this week, an event that further strengthened the strategic alliance between the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital of Sichuan University (WCHSU). The Chinese delegation visited Spain from 26 to 29 November, taking part in a busy schedule of scientific and institutional activities and exchanges between the two centres.

IBEC and SEMIT host the first SEMIT Congress in Barcelona

The Institute for Bioengineering of Catalonia (IBEC) and the Spanish Society of Regenerative Medicine and Tissue Engineering (SEMIT) organized the inaugural SEMIT 2025 Congress. The event gathered leading national and international experts in regenerative medicine and tissue engineering, creating a unique platform for knowledge exchange among researchers, clinicians, and industry.

IBEC and EMBL Barcelona co-organise a matchmaking workshop to explore synergies

Today, the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL) held a matchmaking workshop. The event brought together leading researchers from both centres to encourage the formation of new connections and promote scientific dialogue.

Two IBEC projects receive ERC funding to advance bioinks for 3D printing and cancer therapies

Manuel Salmeron and Xavier Rovira, who are both principal investigators at IBEC, have each been awarded an ERC Proof of Concept Grant. These prestigious grants are awarded by the European Research Council to explore the commercial and social potential of research projects carried out at European institutions. Salmeron’s project, FACTORINK, focuses on designing functional bioinks with biological activity for printing artificial tissues. Meanwhile, Rovira’s project seeks to develop the EVOaware platform, which is designed to address tumour resistance to therapies and accelerate the discovery and development of new cancer treatments.

IBEC and SJD Barcelona Children’s Hospital strengthen their collaboration with a day of translational innovation

The Institute for Bioengineering of Catalonia and the Sant Joan de Déu Barcelona Children’s Hospital have held a joint conference to strengthen collaboration in bioengineering and translational medicine. The event, held this morning at the IBEC, highlighted innovative projects, presented a joint PhD programme and encouraged the exchange of ideas between researchers from both institutions.

IBEC and VHIR hold a collaboration day to promote synergies

The 1st Translational Collaboration Day between the Vall d’Hebron Institute of Research (VHIR) and the Institute of Bioengineering of Catalonia (IBEC), held on 21st November, was an opportunity to learn about the projects and research lines of both institutions and to promote interaction between professionals.

Viscosity of materials key to cell differentiation

An IBEC-led study has revealed how mesenchymal stem cells respond to the viscosity of their environment, a key aspect in their differentiation process. The research, published in Nature Communications, provides new insights that could revolutionise the design of biomaterials for regenerative medicine applications.

IBEC and West China Hospital strengthen collaboration in precision medicine

The second IBEC-WCH Precision Medicine Conference took place last week in Chengdu, China. This is a partnership between the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital (WCH) of Sichuan University, which aims to strengthen scientific collaboration between the two countries.